1. Home
  2. NEUE vs LUCD Comparison

NEUE vs LUCD Comparison

Compare NEUE & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEUE
  • LUCD
  • Stock Information
  • Founded
  • NEUE 2015
  • LUCD 2018
  • Country
  • NEUE United States
  • LUCD United States
  • Employees
  • NEUE N/A
  • LUCD N/A
  • Industry
  • NEUE
  • LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • NEUE
  • LUCD Health Care
  • Exchange
  • NEUE NYSE
  • LUCD Nasdaq
  • Market Cap
  • NEUE 42.7M
  • LUCD 38.4M
  • IPO Year
  • NEUE 2021
  • LUCD 2021
  • Fundamental
  • Price
  • NEUE $4.13
  • LUCD $0.82
  • Analyst Decision
  • NEUE Hold
  • LUCD Strong Buy
  • Analyst Count
  • NEUE 1
  • LUCD 4
  • Target Price
  • NEUE $7.00
  • LUCD $3.63
  • AVG Volume (30 Days)
  • NEUE 8.4K
  • LUCD 644.3K
  • Earning Date
  • NEUE 11-07-2024
  • LUCD 11-13-2024
  • Dividend Yield
  • NEUE N/A
  • LUCD N/A
  • EPS Growth
  • NEUE N/A
  • LUCD N/A
  • EPS
  • NEUE N/A
  • LUCD N/A
  • Revenue
  • NEUE $996,890,000.00
  • LUCD $4,189,000.00
  • Revenue This Year
  • NEUE N/A
  • LUCD $91.80
  • Revenue Next Year
  • NEUE $9.44
  • LUCD $139.27
  • P/E Ratio
  • NEUE N/A
  • LUCD N/A
  • Revenue Growth
  • NEUE N/A
  • LUCD 179.27
  • 52 Week Low
  • NEUE $4.00
  • LUCD $0.63
  • 52 Week High
  • NEUE $16.59
  • LUCD $1.58
  • Technical
  • Relative Strength Index (RSI)
  • NEUE 36.27
  • LUCD 36.68
  • Support Level
  • NEUE $3.99
  • LUCD $0.76
  • Resistance Level
  • NEUE $5.18
  • LUCD $0.83
  • Average True Range (ATR)
  • NEUE 0.34
  • LUCD 0.06
  • MACD
  • NEUE -0.12
  • LUCD -0.01
  • Stochastic Oscillator
  • NEUE 11.77
  • LUCD 22.93

About NEUE NEUEHEALTH INC

NeueHealth Inc is a value driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. It also enables independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally.

About LUCD Lucid Diagnostics Inc.

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Share on Social Networks: